Literature DB >> 26139566

Discrepancies on Medication Plans detected in German Community Pharmacies.

Isabel Waltering, Oliver Schwalbe1, Georg Hempel2.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: A current medication plan was identified as important patient safety factor. Information is needed on how many patients possess such a plan and what problems can be identified with its use. This study tried to define factors that influence accuracy of medication plans and to detect discrepancies from planned and actually administered medication in polypharmacy patients.
METHODS: Participants of the 'Apo-AMTS' course in Germany evaluated medication plans from their patients during performing medication reviews in community pharmacies. Discrepancies were defined as additional or missing drugs and deviations in dosage and drug names for Rx drugs and missing or additional self-medication.
RESULTS: Eighty per cent of the patients possessed a medication plan mainly written by general practitioners. Only 6.5% of the plans showed no discrepancies. Most discrepancies were seen on medication plans written by medical specialists and general practitioners, mainly name aberrations (41%) followed by additional drugs taken (30%) and prescribed drugs no longer taken (18%). Dosage variance was seen in 11% of all discrepancies. Deviations from the plan were observed frequently with antihypertensives (31.4%), analgesics (11.3%) and antidepressants/hypnotics as well as lipid-lowering drugs (6.7%). Four hundred thirty-three OTC drugs were not listed, mainly analgesics, mineral supplements and laxatives.
CONCLUSION: Many patients possess a medication plan but most of these plans showed discrepancies which limits the use as patient safety indicator. Community pharmacies offering medication reviews have an essential position to use the medication plan as a central link between patients and their prescribers, and therefore improve patient safety.
© 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  clinical safety; community pharmacy; discrepancies; medication plan; medication review; patient safety

Mesh:

Substances:

Year:  2015        PMID: 26139566     DOI: 10.1111/jep.12395

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  7 in total

1.  Evaluating patients' comprehensibility of a standardized medication plan.

Authors:  Lea Botermann; Katharina Monzel; Katrin Krueger; Christiane Eickhoff; Angelika Wachter; Charlotte Kloft; Ulrich Laufs; Martin Schulz
Journal:  Eur J Clin Pharmacol       Date:  2016-06-15       Impact factor: 2.953

Review 2.  [Characteristics of pharmacotherapy in older patients with rheumatism].

Authors:  H-J Lakomek; Christian Schulz
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

3.  Patients' handling of a standardized medication plan: a pilot study and method development.

Authors:  Lea Botermann; Katrin Krueger; Christiane Eickhoff; Charlotte Kloft; Martin Schulz
Journal:  Patient Prefer Adherence       Date:  2016-04-22       Impact factor: 2.711

4.  Medication beliefs and use of medication lists - is there a connection? Results from a before-and-after study in Germany.

Authors:  Cornelia Straßner; Cornelia Mahler; Beate Strauß; Ulrich Wehrmann; Katja Krug; Joachim Szecsenyi; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  BMC Geriatr       Date:  2020-03-30       Impact factor: 3.921

5.  Benefits of medication charts provided at transitions of care: a narrative systematic review.

Authors:  Fine Michèle Dietrich; Kurt E Hersberger; Isabelle Arnet
Journal:  BMJ Open       Date:  2020-10-22       Impact factor: 2.692

6.  [How complete is the Germany-wide standardised medication list ("Bundeseinheitlicher Medikationsplan")? An analysis at hospital admission.]

Authors:  Stefanie Amelung; Bianca Bender; Andreas Meid; Stefanie Walk-Fritz; Torsten Hoppe-Tichy; Walter E Haefeli; Hanna M Seidling
Journal:  Dtsch Med Wochenschr       Date:  2020-10-06       Impact factor: 0.628

7.  Prevalence and risk factors of drug-related problems identified in pharmacy-based medication reviews.

Authors:  Raphael Sell; Marion Schaefer
Journal:  Int J Clin Pharm       Date:  2020-02-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.